A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma

Anna Nowak, Michael Millward, Jenette Creaney, Roslyn Francis, Ian Dick, Arman Hasani, A. Van Der Schaaf, A. Segal, Arthur Musk, Michael Byrne

Research output: Contribution to journalArticle

58 Citations (Scopus)
Original languageEnglish
Pages (from-to)1449-1456
JournalJournal of Thoracic Oncology
Volume7
Issue number9
DOIs
Publication statusPublished - 2012

Cite this

@article{2ff09380769944a1b320216140e22e71,
title = "A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma",
author = "Anna Nowak and Michael Millward and Jenette Creaney and Roslyn Francis and Ian Dick and Arman Hasani and {Van Der Schaaf}, A. and A. Segal and Arthur Musk and Michael Byrne",
year = "2012",
doi = "10.1097/JTO.0b013e31825f22ee",
language = "English",
volume = "7",
pages = "1449--1456",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Academic Press",
number = "9",

}

A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma. / Nowak, Anna; Millward, Michael; Creaney, Jenette; Francis, Roslyn; Dick, Ian; Hasani, Arman; Van Der Schaaf, A.; Segal, A.; Musk, Arthur; Byrne, Michael.

In: Journal of Thoracic Oncology, Vol. 7, No. 9, 2012, p. 1449-1456.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma

AU - Nowak, Anna

AU - Millward, Michael

AU - Creaney, Jenette

AU - Francis, Roslyn

AU - Dick, Ian

AU - Hasani, Arman

AU - Van Der Schaaf, A.

AU - Segal, A.

AU - Musk, Arthur

AU - Byrne, Michael

PY - 2012

Y1 - 2012

U2 - 10.1097/JTO.0b013e31825f22ee

DO - 10.1097/JTO.0b013e31825f22ee

M3 - Article

VL - 7

SP - 1449

EP - 1456

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 9

ER -